Metformin Fairmed (Metformin Hydrochloride)

Metformin primarily inhibits hepatic gluconeogenesis through activation of AMP‑activated protein kinase (AMPK). It also reduces intestinal glucose absorption and increases peripheral insulin sensitivity, which together lead to lower circulating glucose concentrations.

The dose of Metformin Fairmed is individualized by the prescribing clinician based on the patient’s glycaemic targets, renal function, and tolerability. The prescriber determines the appropriate strength, frequency, and titration schedule.

Safety in pregnancy and lactation has not been definitively established. Metformin should only be used during pregnancy if the potential benefit to the mother outweighs any possible risk to the fetus, and breastfeeding mothers should consult their healthcare provider.

To place an order, submit an enquiry on the Metformin Fairmed product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metformin is the first‑line therapy for type 2 diabetes because of its efficacy, low risk of hypoglycaemia, and favourable impact on weight. Compared with sulfonylureas or insulin, it does not cause weight gain and has a well‑documented cardiovascular safety profile.

Metformin Fairmed tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Metformin Fairmed is taken orally, usually with meals to minimise gastrointestinal discomfort. The tablets are swallowed whole with a glass of water; they should not be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

The most serious adverse effect is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, dehydration, or excessive alcohol intake. Prompt medical attention is required if symptoms such as unexplained fatigue, rapid breathing, or abdominal pain develop.

Metformin Fairmed is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in those receiving iodinated contrast studies without appropriate renal monitoring.